v3.25.4

Weighted average basic and diluted number of common shares outstanding

9 Months Ended

Sep. 30, 2025

Weighted average basic and diluted number of common shares outstanding

Weighted average basic and diluted number of common shares outstanding

16. Weighted average basic and diluted number of common shares outstanding

		Three-month				Three-month				Nine-month				Nine-month
		period ended				period ended				period ended				period ended
		September 30,				September 30,				September 30,				September 30,
		2025				2024				2025				2024
Basic weighted average number of shares			271,451,602				105,053,467				260,988,191				98,314,006
Effect of dilutive stock options and warrants			-				-				-				-
Diluted weighted average number of shares			271,451,602				105,053,467				260,988,191				98,314,006

Diluted weighted average number of common shares for the three-month and nine-month periods ended September 30, 2025 excludes nil anti-dilutive preferred shares (2024: nil), 9,103,338 anti-dilutive stock options (2024: 5,978,000) and 8,108,440 anti-dilutive warrants (2024: 15,104,008).

X

- Definition

The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	usas_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsTextBlockAbstract
Namespace Prefix:	usas_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration